Please ensure Javascript is enabled for purposes of website accessibility

Kentucky House of Representatives Passes Medical Pot Bill

By Eric Volkman - Feb 23, 2020 at 11:51AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The bill is the latest indication of changing attitudes towards marijuana legalization in the U.S. South.

The Kentucky House of Representatives approved a medical marijuana legalization bill on Thursday. The vote was 65 representatives in favor, with 30 against. The bill now goes to the state's Senate for approval; if it passes in that chamber and is signed by Governor Andy Beshear, it will become law.

The news comes barely a week after the proposed law overwhelmingly passed in the House's judiciary committee. 

Medical professional holding cannabis products.

Image source: Getty Images.

Meanwhile, a similar bill is also rapidly moving through the Alabama legislature.

Both developments indicate a potential thaw in the approach of southern states to marijuana legalization. Unlike other regions in the U.S., no southern state permits both recreational and medical cannabis. In fact, three states in the region -- Alabama (at present), South Carolina, and Tennessee -- bar all forms of the drug, and have never decriminalized it.

Even their first steps toward medical marijuana legalization seem tentative. Both Kentucky's and Alabama's bills are restrictive compared to medical cannabis laws that have been passed in other states.

In Kentucky's case, prescriptions of the drug would be limited to a number of ailments determined by a state regulatory board. And like Alabama's bill, Kentucky's does not permit the sale of cannabis products that can be smoked.

In the most likely scenario, big marijuana companies would try to crack the Kentucky market if the bill ultimately passes into law. Green Thumb Industries (GTBIF -2.29%) and Cresco Labs (CRLBF 1.10%) are both based in neighboring Illinois, and have enjoyed robust business in their home state. Making a push across the border would be a sensible move, although neither Green Thumb nor Cresco has indicated plans to do so.

On Friday, Green Thumb stock dipped by 3%, while Cresco rose by slightly over 1%.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Green Thumb Industries Stock Quote
Green Thumb Industries
GTBIF
$12.82 (-2.29%) $0.30
Cresco Labs Inc. Stock Quote
Cresco Labs Inc.
CRLBF
$3.94 (1.10%) $0.04

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
345%
 
S&P 500 Returns
119%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/16/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.